novartis_window

Novartis to bolster oncology portfolio with $3.9 billion acquisition

October 30, 2017
Sales and Marketing Advanced Acclerator Applications, Lutathera, Novartis, pharma

Novartis has announced its intention to acquire France’s Advanced Accelerator Applications (AAA) for $3.9 billion in a move to reinforce …

merckentranceweb

Samsung Biologics reinforces biologic manufacturing and development partnership with MSD

October 30, 2017
Manufacturing and Production, Sales and Marketing Korea, MSD, Samsung BioLogics, pharma

Samsung Biologics has announced it has expanded its strategic alliance with MSD, or Merck as it is known in the …

pfizer-building-logo1web

Switching Crohn’s patients to biosimilar Inflectra from Remicade is safe and effective, Pfizer says

October 30, 2017
Research and Development, Sales and Marketing Crohn’s disease, Pfizer, Remicade, crohn's disease, inflectra, pharma

Pfizer has released new data on its Crohn’s disease (CD) treatment Inflectra (infliximab CT-P13) which indicate that switching patients to …

4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

October 27, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

October is almost over and Halloween is just around the corner, and it’s time for another run-down of the stories …

cyber-security-1923446_960_720

NHS was crippled by “unsophisticated” cyber attack

October 27, 2017
Medical Communications NHS, biotech, drugs, pharma, pharmaceutical

Back in May of this year, the NHS was hit by a cyber attack that severely impacted at least 34% …

shutterstock_138095450

Insys Pharma founder charged over “nationwide conspiracy” to illegally distribute fentanyl

October 27, 2017
Medical Communications, Sales and Marketing Insys Pharma, Subsys, fentanyl, opioid crisis, opioids

John N Kapoor, the 74-year old founder of Insys Pharma, has been legally charged over his involvement in driving a …

celgene_exteriors-3

Celgene hikes price of Revlimid to mask poor Q3 results

October 27, 2017
Medical Communications, Sales and Marketing Celgene, Revlimid, biotech, drugs, pharma, pharmaceutical

Celgene posted its Q3 results and investors did not react well – shares plunged 16% immediately, after the biotech cut …

abbvieuse_054_low

AbbVie’s psoriasis drug smashes all endpoints

October 26, 2017
Medical Communications, Research and Development AbbVie, IL-23, biotech, drugs, pharma, pharmaceutical, risankizumab

AbbVie already know well what it’s like to have a lead candidate in the psoriasis field, after having Humira sat …

amber_hr_2

Is the NHS prepared for the upcoming winter season?

October 26, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Insider Interview, Interview, NHS, pharma

After the health service struggled through the same period last year, Amber Jabbal, Head of Policy at NHS Providers sets …

gsk_wall

GSK eyes healthcare expansion, hits targets due to new drugs

October 26, 2017
Sales and Marketing GSK, Merck KGaA, Pfizer, biotech, drugs, healthcare, pharma, pharmaceutical

During the release of Q3 figures, GlaxoSmithKline’s CEO, Emma Walmsley, revealed that the company would consider making moves to bolster …

Pfizer to begin auction of consumer health division next month

October 26, 2017
Sales and Marketing GSK, Pfizer, Proctor & Gamble, Sanofi, nestle

Following the recent revelation that Pfizer was considering the spin-out of its consumer health division, it has now emerged that …

doctor-840127_960_720

NHS patients could be offered Airbnb-like accommodation

October 26, 2017
Medical Communications NHS, biotech, drugs, pharma, pharmaceutical

In a sign of how desperate the hospital bed situation across the UK is, one council has looked into piloting …

regeneron

Regeneron injects $100 million and 300 new roles into Irish production facility

October 26, 2017
Manufacturing and Production Regeneron, Sanofi, manufacturing, pharma

Sanofi subsidiary Regeneron has announced its intention to expand its production plant in Limerick, Ireland – the largest scale bulk …

Mental health problems cause 300,000 to leave work each year

October 26, 2017
Research and Development biotech, drugs, mental health, pharma, pharmaceutical

A report commissioned by Prime Minister, Theresa May, has found that 300,000 people are leaving their positions of work after …

Sanofi launches patent infringement lawsuit against Mylan over diabetes pen

October 25, 2017
Research and Development, Sales and Marketing Basaglar, Eli Lilly, Lantus, Mylan, Sanofi, diabetes, insulin, patent infringement, pharma

Sanofi has launched a lawsuit against Mylan as part of a dispute that alleges that the latter infringed upon 18 …

lilly2_web

Lilly looks to leave behind animal health business

October 25, 2017
Research and Development, Sales and Marketing Elanco, Eli Lilly, biotech, drugs, pharma, pharmaceutical

Eli Lilly released its Q3 financials and the major talking point was the announcement that the business was reviewing “strategic …

GSK’s ‘bubble boy’ gene therapy secures NICE recommendation despite high cost

October 25, 2017
Research and Development, Sales and Marketing GSK, GlaxoSmithKline, Strimvelis, pharma

GSK has received good news from NICE as it is revealed that Strimvelis, its gene therapy treatment for adenosine deaminase …

8384110298_da510e0347_c

Research finds blood-thinners protect against dementia

October 25, 2017
Research and Development Alzheimer's, anticoagulant, biotech, dementia, drugs, pharma, pharmaceutical

Blood-thinning drugs are commonly used to reduce stroke risk in patients with atrial fibrillation (AF) but research from the Karolinska …

diabetes-2424105_960_720

Type 3 diabetes more common than Type 1 and often misdiagnosed

October 25, 2017
Research and Development biotech, diabetes, drugs, pharma, pharmaceutical

In the first ever study of its kind, researchers from the University of Surrey examined the records of more than …

The Gateway to Local Adoption Series

Latest content